drugset / Trial / NCT03147378

Food Effect Study of ModraDoc006 in Combination With Ritonavir

NCT03147378 ↗

RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the effect of food on the pharmacokinetics of ModraDoc006 in combination with ritonavir, in an open-label, cross-over design. Patients will be randomized into two treatment groups receiving ModraDoc006/r week 1 under fasting and week 2 under fed condition, or vice versa.

Timeline

Start
2017-05-10
Primary completion
2018-04-04
Completion
2018-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule 30 mg Oral
Subject Ritonavir Other / unclassified 100 mg Oral

Indications